Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lenihan

Showing results (61-70 of 200) with videos related to

Pageof 20
Sort By:
Heart Failure Clinics|September 2, 2019
Hypertension in the Cardio-Oncology ClinicLauren J Hassen, Daniel J Lenihan, Ragavendra R Baliga
Nature Clinical Practice. Cardiovascular Medicine|May 21, 2008
Sunitinib-related cardiotoxicity: an interdisciplinary issueMichael S Ewer, Daniel J Lenihan, Aarif Y Khakoo
The American Journal of Medicine|May 1, 2007
Wrap beatsSyed Wamique Yusuf, Jean-Bernard Durand, Daniel J Lenihan
Journal of the American College of Cardiology|February 1, 2020
Cardiac PET/CT-Determined Amyloid Light Chain Depositions: A New Risk Biomarker?Thomas H Schindler, Robert J Gropler, Daniel J Lenihan
The American Journal of the Medical Sciences|October 20, 2005
Endovascular repair of abdominal aneurysms: Is this the method of choice?Blaithnead Mary Murtagh, Daniel J Lenihan, Richard W Smalling
Catheterization and Cardiovascular Diagnosis|May 1, 1991
Left main coronary artery aneurysm in association with severe atherosclerosis: a case report and review of the literatureD J Lenihan, H S Zeman, G J Collins
Internal Medicine Journal|August 24, 2007
Air embolism in the right ventricleS W Yusuf, M T Troung, D J Lenihan
Current Treatment Options in Cardiovascular Medicine|April 9, 2018
Advances in Treatment of Cardiac AmyloidCherie N Dahm, R Frank Cornell, Daniel J Lenihan
The Oncologist|July 12, 2011
Cardiovascular toxicity profiles of vascular-disrupting agentsIshwaria M Subbiah, Daniel J Lenihan, Apostolia M Tsimberidou
The Biochemical Journal|April 28, 2026
Target discrimination and PAM profiling of the Thermotoga maritima type I-B CRISPR systemJohn Mallon, Charles J Lenihan, Sowmyaa Shridhar, et al.
Pageof 20

Showing results (61-70 of 200) with videos related to

Sort By:
Pageof 20
Heart Failure Clinics|September 2, 2019
Hypertension in the Cardio-Oncology ClinicLauren J Hassen, Daniel J Lenihan, Ragavendra R Baliga
Nature Clinical Practice. Cardiovascular Medicine|May 21, 2008
Sunitinib-related cardiotoxicity: an interdisciplinary issueMichael S Ewer, Daniel J Lenihan, Aarif Y Khakoo
The American Journal of Medicine|May 1, 2007
Wrap beatsSyed Wamique Yusuf, Jean-Bernard Durand, Daniel J Lenihan
Journal of the American College of Cardiology|February 1, 2020
Cardiac PET/CT-Determined Amyloid Light Chain Depositions: A New Risk Biomarker?Thomas H Schindler, Robert J Gropler, Daniel J Lenihan
The American Journal of the Medical Sciences|October 20, 2005
Endovascular repair of abdominal aneurysms: Is this the method of choice?Blaithnead Mary Murtagh, Daniel J Lenihan, Richard W Smalling
Catheterization and Cardiovascular Diagnosis|May 1, 1991
Left main coronary artery aneurysm in association with severe atherosclerosis: a case report and review of the literatureD J Lenihan, H S Zeman, G J Collins
Internal Medicine Journal|August 24, 2007
Air embolism in the right ventricleS W Yusuf, M T Troung, D J Lenihan
Current Treatment Options in Cardiovascular Medicine|April 9, 2018
Advances in Treatment of Cardiac AmyloidCherie N Dahm, R Frank Cornell, Daniel J Lenihan
The Oncologist|July 12, 2011
Cardiovascular toxicity profiles of vascular-disrupting agentsIshwaria M Subbiah, Daniel J Lenihan, Apostolia M Tsimberidou
The Biochemical Journal|April 28, 2026
Target discrimination and PAM profiling of the Thermotoga maritima type I-B CRISPR systemJohn Mallon, Charles J Lenihan, Sowmyaa Shridhar, et al.
Pageof 20